Optimizing surveillance of low-risk metabolic dysfunction associated steatotic liver disease using transient elastography

Most people with metabolic dysfunction-associated steatotic liver disease (MASLD) lack significant fibrosis and are considered low-risk. Surveillance strategy for low-risk MASLD remains uncertain.